Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $158.29 -0.45%
EPS Growth %: -5.5%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -5.5%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $1.24, $0.12 better than the analyst estimate of $1.12. Revenue for the quarter came in at $412 million versus the consensus estimate of $408.87 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Stifel downgrades Intuit to Hold on growth concerns, cuts target price
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
